SUN PHARM INDS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDS, and what generic alternatives to SUN PHARM INDS drugs are available?
SUN PHARM INDS has two hundred and twenty-five approved drugs.
There are three US patents protecting SUN PHARM INDS drugs. There are eleven tentative approvals on SUN PHARM INDS drugs.
There are three patent family members on SUN PHARM INDS drugs in three countries and two hundred and nineteen supplementary protection certificates in sixteen countries.
Summary for SUN PHARM INDS
International Patents: | 3 |
US Patents: | 3 |
Tradenames: | 167 |
Ingredients: | 158 |
NDAs: | 225 |
Drugs and US Patents for SUN PHARM INDS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Ltd | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065132-001 | Mar 19, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Inds Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 090659-005 | Nov 6, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Inds | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 091626-001 | Oct 31, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUN PHARM INDS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 7,435,427 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-006 | Aug 15, 2014 | 8,952,064 | ⤷ Try a Trial |
Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
International Patents for SUN PHARM INDS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 3346996 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2017042835 | ⤷ Try a Trial |
Japan | 2018530535 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for SUN PHARM INDS Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0162036 | C300028 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929 |
0454436 | SPC/GB96/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: OLANZAPINE OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT; REGISTERED: UK EU/1/96/022/001 19960927; UK EU/1/96/022/002 19960927; UK EU/1/96/022/003 19960927; UK EU/1/96/022/004 19960927; UK EU/1/96/022/005 19960927; UK EU/1/96/022/006 19960927; UK EU/1/96/022/007 19960927; UK EU/1/96/022/008 19960927; UK EU/1/96/022/009 19960927; UK EU/1/96/022/010 19960927 |
1506211 | C 2014 029 | Romania | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE DE DAPAGLIFLOZIN SAU O SARE ACCEPTABILAFARMACEUTIC A ACESTUIA SI METFORMINA SAU O SARE ACCEPTABILA FARMACEUTIC A ACESTEIA; NATIONAL AUTHORISATION NUMBER: EU/1/13/900; DATE OF NATIONAL AUTHORISATION: 20140116; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/13/900; DATE OF FIRST AUTHORISATION IN EEA: 20140116 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.